PRZOOM - /newswire/ -
Noida, Uttar Pradesh, India, 2010/06/15 - With increasing number of cancer patients and rising health insurance coverage, the global monoclonal antibodies market will hit a CAGR of 13% during 2010-2013, says a latest research report from RNCOS.
As per our new research report “Global Protein Therapeutics Market Analysis”, the global monoclonal antibodies market is expected to witness stupendous growth in the coming years. Extensive research and profound analysis performed for the market together exhibited a high growth potential market with promising growth prospects inherent for the industry.
Considering the increasing government expenditure on healthcare coupled with the increasing generic competition, it is forecasted that the market will grow at a CAGR of around 13% during 2010-2013. Further, relative abundance of niches for monoclonal antibody therapy applications and a staggering number of potential disease targets will fuel the growth of the monoclonal antibody therapies globally.
We have identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that increase in the health insurance industry will drive renewed interest of the investors in the therapeutics market at the global level. Moreover, higher incidence of lifestyle and chronic diseases such as cancer, arthritis, etc. will pave the way for the growth of the market in coming years.
Besides this, our report also provides a thorough research and prudent analysis of global protein therapeutics market. The systematic and thorough research studies the global protein therapeutics market to give an insight into its various segments including Monoclonal Antibodies, Erythropoietins, Insulin, Interferon, Human Growth Hormone, Blood Clotting Factor, Granulocyte Colony Stimulating Factor and Follicle Stimulating Hormone. The comprehensive analysis of the market states monoclonal antibodies as the highest shareholder at present, but future will see insulin segment posting a rapid growth.
“Global Protein Therapeutics Market Analysis” provides thorough research and rational analysis along with reliable statistics on the global protein therapeutics market. The report also provides extensive information on the traditional markets as well as on the emerging technologies. Also, an insight of trends prevailing in the regional protein therapeutics market segments across the globe has been covered in the report. Analysis and statistics regarding market size, growth, share, segmentation and geographic distribution have been included in the report to give a comprehensive view of the global protein therapeutics market. The report also covers current industrial developments and competitive landscape to help clients understand the current structure of the market and its progress in coming years.
RNCOS (rncos.com) specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.